ESSA Pharma Stock Options

EPIX Stock

USD 2.97 0.08 2.62%

ESSA Pharma's option chain provides insight into all available option contracts written on ESSA Pharma's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of ESSA Pharma's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given ESSA Pharma option contract. View S&P 500 options

Purchasing ESSA Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ESSA Pharma calls. Remember, the seller must deliver ESSA Pharma stock to the call owner when a call is exercised.

In The Money vs. Out of Money Option Contracts on ESSA Pharma

Analyzing ESSA Pharma's in-the-money options over time can help investors to take a profitable long position in ESSA Pharma regardless of its overall volatility. This is especially true when ESSA Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ESSA Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with ESSA Pharma's stock while costing only a fraction of its price.

ESSA Pharma's latest option contracts expiring on 2023-04-21 are carrying combined implied volatility of 139.1 with a put-to-call open interest ratio of 0.78 over 6 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2023-04-21. The current put volume is at 136, with calls trading at the volume of 3. This yields a 45.33 put-to-call volume ratio. The ESSA Pharma option chain provides detailed quote and price information for the current ESSA Pharma option contracts. It shows all of ESSA Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.

Open Interest Against 2023-04-21 Option Contracts

ESSA Pharma option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in ESSA Pharma's lending market. For example, when ESSA Pharma's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on ESSA Pharma, he or she must hedge the risk by shorting ESSA Pharma stock over its option's life.

The chart above shows ESSA Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ESSA Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ESSA Pharma's option, there is no secondary market available for investors to trade.

ESSA Pharma's stock options are financial instruments that give investors the right to buy or sell shares of ESSA Pharma common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ESSA Pharma stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ESSA Pharma's stock price goes up or down, the stock options follow.

Check out Investing Opportunities. For more information on how to buy ESSA Pharma Stock please use our How to Invest in ESSA Pharma guide.

Please note that buying 'in-the-money' options on ESSA Pharma lessens the impact of time decay, as they carry both intrinsic and time value. So, even if ESSA Pharma's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money ESSA Pharma contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if ESSA Pharma Stock moves the wrong way.

Net Income Common Stock is likely to drop to about (32.4 M) in 2023

ESSA Pharma Current Options Market Mood

ESSA Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ESSA Pharma Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of ESSA Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. ESSA Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current ESSA Pharma's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current ESSA Pharma contract

Base on the Rule 16, the options market is currently suggesting that ESSA Pharma will have an average daily up or down price movement of about 8.69% per day over the life of the 2023-04-21 option contract. With ESSA Pharma trading at USD2.97, that is roughly USD0.26. If you think that the market is fully incorporating ESSA Pharma's daily price movement you should consider buying ESSA Pharma options at the current volatility level of 139.1%. But if you have an opposite viewpoint you should avoid it and even consider selling them.

ESSA Pharma Valuation Risk

ESSA Pharma Option Chain

When ESSA Pharma's strike price is surpassing the current stock price, the option contract against ESSA Pharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.

2023-04-21 2023-05-19 2023-07-21 2023-10-20

ESSA Pharma's option chain is a display of a range of information that helps investors for ways to trade options on ESSA Pharma. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ESSA Pharma. It also shows strike prices and maturity days for a ESSA Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

		Delta	Gamma	Open Int	Expiration	Current Spread	Last Price
Call	2023-04-21 CALL at $2.5	0.7477	0.298	1718	2023-04-21	0.45 - 0.9	0.8	In
Put	2023-04-21 PUT at $2.5	-0.2234	0.356	917	2023-04-21	0.05 - 0.2	0.25	Out
Put	2023-04-21 PUT at $5.0	-0.5778	0.1569	347	2023-04-21	1.85 - 3.2	2.55	In
Put	2023-04-21 PUT at $7.5	-0.681	0.1245	346	2023-04-21	4.0 - 4.9	4.71	In

ESSA Pharma Net Income Common Stock Over Time

The amount of net income (loss) for the period due to common shareholders. Typically differs from Net Income to the parent entity due to the deduction of Preferred Dividends.

Net Income Common Stock

Timeline

ESSA Pharma Historical Liabilities

While analyzing the current debt level is an essential aspect of forecasting the current year budgeting needs of ESSA Pharma, understanding its historical liability is critical in projecting ESSA Pharma's future earnings, especially during periods of low and high inflation and deflation. Many analysts look at the trend in assets and liabilities and evaluate how ESSA Pharma uses its financing power over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in ESSA Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio

All Next

Launch Module

Pair Trading with ESSA Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ESSA Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will appreciate offsetting losses from the drop in the long position's value.

Moving together with ESSA Pharma

+	0.73	MGTA	Magenta Therapeutics	Earnings Call Today	Pair Corr
+	0.65	MIRM	Mirum Pharmaceuticals	Fiscal Quarter End 31st of March 2023	Pair Corr
+	0.75	MORF	Morphic Holding	Fiscal Quarter End 31st of March 2023	Pair Corr
+	0.7	MRUS	Merus BV	Fiscal Quarter End 31st of March 2023	Pair Corr
+	0.87	VRCA	Verrica Pharmaceuticals	Fiscal Quarter End 31st of March 2023	Pair Corr

Moving against ESSA Pharma

-	0.69	ENOB	Enochian Biosciences		Pair Corr
-	0.66	NBIX	Neurocrine Biosciences	Fiscal Quarter End 31st of March 2023	Pair Corr
-	0.61	MRNA	Moderna	Fiscal Quarter End 31st of March 2023	Pair Corr
-	0.56	OCGN	Ocugen Inc	Fiscal Quarter End 31st of March 2023	Pair Corr

The ability to find closely correlated positions to ESSA Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ESSA Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ESSA Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ESSA Pharma to buy it.

The correlation of ESSA Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ESSA Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ESSA Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for ESSA Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out Investing Opportunities. For more information on how to buy ESSA Pharma Stock please use our How to Invest in ESSA Pharma guide. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for analysis

When running ESSA Pharma price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Transaction History View history of all your transactions and understand their impact on performance
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios

Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA Pharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.74)

Return On Assets

(0.13)

Return On Equity

(0.19)

The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA Pharma that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine ESSA Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

ESSA Pharma Stock Options

In The Money vs. Out of Money Option Contracts on ESSA Pharma

Open Interest Against 2023-04-21 Option Contracts

ESSA Pharma Current Options Market Mood

Put-to-Call Open Interest

Put-to-Call Volume

Rule 16 of the current ESSA Pharma contract

ESSA Pharma Option Chain

ESSA Pharma Net Income Common Stock Over Time

ESSA Pharma Historical Liabilities

Be your own money manager

Did you try this?

Run Idea Optimizer Now

Idea Optimizer

Pair Trading with ESSA Pharma

Moving together with ESSA Pharma

Moving against ESSA Pharma

Complementary Tools for analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY